Mission and scope

Science Translational Medicine Mission: Science Translational Medicine is the leading weekly online journal publishing research at the intersection of science, engineering and medicine. The goal of Science Translational Medicine is to promote human health by providing a forum for communicating the latest research advances from biomedical, translational, and clinical researchers from all established and emerging disciplines relevant to medicine. Despite 50 years of progress in our fundamental understanding of human biology and the emergence of powerful new technologies, the translation of this knowledge into effective new treatments and health measures has been slow. Science Translational Medicine seeks to publish articles that fill the scientific knowledge gaps at the junction of preclinical research and medical applications in order to accelerate the translation of this knowledge into new ways for preventing, diagnosing and treating human disease.

Content: Science Translational Medicine publishes original, peer-reviewed, science-based research articles that report successful advances toward the goal of improving patients' lives. The editors and an international advisory group of scientists and clinician-scientists as well as other experts hold Science Translational Medicine articles to the same high-quality standard that is the hallmark of the journal Science.

Scope: Cardiovascular disease, immunology/vaccines, metabolism/diabetes/obesity, neuroscience/neurology/psychiatry, cancer, infectious diseases, policy, behavior, bioengineering, chemical genomics/drug discovery, imaging, applied physical sciences, medical nanotechnology, drug delivery, biomarkers, gene therapy/regenerative medicine, toxicology and pharmacokinetics, data mining, cell culture, animal and human studies, medical informatics, and other interdisciplinary approaches to medicine.


Examples of content in Science Translational Medicine:

  • Investigative studies of human biology with an emphasis on disease, including small clinical trials
  • Research on models of human disease with significant implications for disease treatment
  • Focus, Perspectives and Reviews that discuss medically related research from a basic science and a clinical point of view
  • Commentary on policy, funding, education and regulatory issues in translational medicine
  • Survey of recent noteworthy findings from other publications (Editor's Choice)
  • Special issues that feature comprehensive reviews and analyses of current topics in translational medicine

Audience: Researchers and management in academia, government, and the biotechnology and pharmaceutical industries; physician scientists; regulators; policy makers; investors; business developers; and funding agencies.

Issue Elements: Approximately 1,500 print pages per year, 12-16 original peer-reviewed full-length research papers per month.

Personalization: Science Translational Medicine provides customization features to tailor the site to the user's needs and interests (these features require registration and access through an institutional site license). Science Translational Medicine offers eTOC alerts, which alert users when a new issue of Science Translational Medicine is published, as well as three types of CiteTrack research alerts: (i) keyword alerts, (ii) author alerts, and (iii) citation alerts.

Users also can organize Science Translational Medicine content in Folders; select display settings that provide filters for searches; and save personalized searches to execute on demand.